CryoMass Technologies Inc (CRYM)

[Runlebbyrun]

Will what take?

[Blixem]

My goodness. How long will this take? Max. days is 5 workdays?

[W_vdm]

Late filing notification: https://www.sec.gov/Archives/edgar/data/1533030/000121390023087011/ea188431-nt10q_cryomass.htm

Reason: The Company is unable to file its quarterly report on Form 10-Q for the period ended September 30, 2023 within the time prescribed without unreasonable effort and expense, due to complex questions regarding revenue recognition in accordance with generally accepted accounting principles.

So bad news: late filing = frowned upon and possibly sign of management not doing what they should be doing.
Good news: they're not filing as they don't know how to recognize revenue correctly. That means there is revenue!

If it dumps on the news it will probably be the best risk/reward buy moment for this stock.

[W_vdm]

10q coming this week normally, so we'll know soon enough how much revenue they realised by now.

On the technical side there isn't much to be happy about. Only a potential double bottom pattern forming... to be seen if it completes. It would lead to a price target of +-0,28

[Runlebbyrun]

It's about time for some positive news.

[mxp]

Does JEFF still stand by his predictions? Considering that we plunged so hard...

[Witte44]

600 shares traide=Apply resistance at the ASK to keep the price from increasing (MM-code)

[Runlebbyrun]

This thing will be huge!!!
Price is a steal....

[byobnet]

From today's ASM. CEO Christian Noel: 'We are currently engaged in advanced discussions with several companies in three different geographical areas, which present significant revenue potential for our company. Our pipeline of interested companies is robust and geographically diverse, and we are prioritizing companies with substantial cultivation and processing footprints. Our focus has been to engage with established companies to gain a deeper understanding of their specific needs and identify key areas where CryoMass can provide value.'

Exciting times!

[Liza and Louise]

The CEO and CFO did some insider buying this month.
https://finance.yahoo.com/quote/CRYM/insider-transactions?p=CRYM

[W_vdm]

Another update in the new investors presentation the measurement in performance of cryomass vs traditional systems.

Sept 2022:
Cryomass biomass process / hour: up to 1300lbs (22x more compared to traditional)
Cryomass seperation time in days: 1,6 (41x faster to traditional)

March 2023
Cryomass biomass process / hour: up to 1300lbs (12x more to traditional)
Cryomass seperation time in days: 1,6 (22x faster to traditional)

I assume they updated it as a result of extra tests. They are "less good" but still better by a wide margin than the traditional way.

[W_vdm]

Updated investor presentation on the site: https://cryomass.com/wp-content/uploads/2023/03/CRYOMASS-MARCH-2023.pdf

Biggest changes:
- mention of the $10.2m + royalty deal
- New image of their machine (after the recent adjustments)
- What comes next slide:
1. We are presently in the design phase of the CryoMass harvester module. This purpose-built field equipment is meant to cut fresh plants, flash freeze them and separate the biomass from the stalk, so it is ready to be processed in the CryoMass Trichome Separation unit.
2. The company believes that efficiencies delivered by the CryoMass solution will trigger industrywide changes in the handling and processing of harvested cannabis and hemp.
3. CryoMass is also exploring the application of the underlying technology to a broad range of industries that handle high-value materials that could benefit from precision capture methods.

[W_vdm]

Matt Armstrong shared a video on Instagram yesterday. You might need to follow him first before you can see it. It's a video of the working Cryomass system and the output of the process. Matt is one of the inventors of the process and is director of innovation at Cryomass.

Link to his account: https://www.instagram.com/strait_concentrates/

The text he added to the video:

"History in the making is right and this is just the tip of the iceberg!!! Hats off to the entire team and everyone who believed in us all over the years! It’s indescribable the feeling I felt when we turned on and fed the first fresh frozen through the system and she ran perfectly!! As with all things in life, plenty to tinker and play with to continue to maximize efficiency and quality, but that being said we hit the mark!!!! If you think this party starts and stop in the cannabis world, buckle up because it’s going to be a wild ride!! Next up, after we destroy the hops game(low hanging fruit) is time to start working to reclaim the land we’ve destroyed as a species and correcting centuries of mistakes! This technology reaches far and wide!! What we can affect and accomplish is limitless and only bound by the mind!!! Last but never least, too my amazing wife @mermaidmedibles and all 5 littles, thank you for allowing me the freedom to follow my path no matter where it has led me!! Weeks, months, even a year away, and nothing but support and strength!! Without you I would be nothing!! Cheers!!!"

[Witte44]

Ready for takeoff.

[W_vdm]

Thanks for reminding me, I'm not that active on this forum.

I had a call with the Jérémy St-Pierre, responsible for investor relations at the company. These are the notes I took from the call (not in a particular order of importance):

This is translated from a communication I sent to several people in Dutch, so sometimes extra context is added as some of the target audience aren't that familiar with the company.

1. With the first license contract, they receive $850k per machine. Note that they do not sell the machine, Cryomass remains the owner, and the license fee is for the use of the machine. In addition, Cryomass also receives 50% of the net revenue from the machine (Revenue - Operating costs (1 to 2 personnel & cost of liquid nitrogen)).

2. The $850k is not a fixed price. This may be higher if the partner wants exclusivity in a certain region. This may be lower if it is commercially interesting for Cryomass. RedTape (partner taking the first license) received a discount as they are the first partner. The price can also vary depending on the type of plant for which it is applied. For crops with higher margins, higher prices can be charged.

3. Production of systems is not done by themselves, but by a partner company. The production process itself is not so complicated, so they are not dependent on one partner. They are looking for diversification in this to be able to produce faster and be less dependent on one company. The cost price of 1 installation was estimated to be around $500k. So the current license fee is enough to finance machines up front without Cryomass having to take on debt or dilute their shares.

4. They have patents in the USA/Canada until 2039 for their concept/process. So even if it is easy to replicate, no one can use it without their approval. Patent applications in other relevant countries have been filed/are in the process of approval.

5. The first system is available at their partner in California and also serves as a showcase model/proof of concept for the market. There is interest not only from the cannabis/hemp industry but also from other crops (such as hops for beer brewing). They have received many requests to see their machine and partnership requests. There is no immediate need to set up a sales team as there is a lot of "organic" interest.

6. They are making a few adjustments (fine-tuning) to their current machine concept. They are of course learning as they go from practice. The estimate was that the second, adjusted machine could be delivered by May. From then on, they would be able to deliver more and more quickly. The bulk of the hemp/cannabis harvest season is in September, (cr)optober, November. By then, they want to have delivered 4 machines already.

7. The expectation is that royalty revenues will be many times greater than the upfront license fees. The exact estimate could not be given (not publicly disclosed), but it strongly depends on a good partner (who ensures uptime of their machine). Next quarter reporting will provide more clarity on this. Q1 report may be a catalyst for share price (10-k was released end of March last year).

8. Keep in mind that the USA is a growing market that currently has around $5.5 billion in wholesale revenue (in which they are active). 50% of the market is for the plant, 50% for the trichomes/active ingredients. That is still a market of $2.75 billion. Only for the USA, only for Hemp.

9. They have no competition in their technology (shielded by patents). Other technologies try to separate based on water, which has considerably higher costs and cannot process as large quantities as CryoMass.

10. They are already considering on developing new machines before and after the Cryo process. For example, making sure the machine can easily be taken to the field. The faster the plant is frozen, the more valuable trichomes remain intact. They are also looking at separators that will freeze less biomass (without trichomes).

11. They are considering an uplisting to a larger stock exchange. This will not happen/be announced before the fall of 2023 at the earliest. First, they want to show a few quarters of revenue + revenue growth and let the share price grow organically.

12. So far, they have never engaged in marketing, and it was not really necessary. To sell their product, they will not do this for the time being because they are receiving a lot of interest from their target sector and even beyond. They have many requests for partnerships, which limits sales/marketing costs. However, they will start to generate more publicity around the stock. Within a month or two, there will be more frequent updates on their progress, as well as the company's participation in conferences or maybe even an investor day. The exact format is not yet known, but it is clear that they will focus extra attention on this. It is still flying under the radar, but maybe not for much longer.

13. Shareholders: the largest is CRYM Co-Invest LP (11%). This is a fund set up by investment professionals from the real estate world in Vancouver who are connected through CEO (Christian Noel). The second-largest shareholder is CryoCann USA Corporation (4.9%), which is the vehicle of the inventors of the cryo technology. These are engineering profiles who used their resources to initially develop the technology. They needed more resources & commercial skills bring the commercialization in motion. By setting up Cryomass, a collaboration was established in which the product could be further developed and commercialization could be accelerated. Matt Armstrong, one of the inventors & shareholders of CryoCann USA corporation, is still the Director of Innovation today. The third-largest shareholder is the CEO himself (4.52%).

14. $251k in stocks were bought by insiders in January (by CEO, CFO & head of legal)

15. The CEO's interest is the same as that of the shareholder. He owns 4.5% of the shares and continues to buy more. The largest shareholder are his finance/real estate friends from Vancouver.

[paul_dirac]

Did you get a reply?

[W_vdm]

Great news from earlier this week: https://cryomass.com/2023/01/cryomass-signs-10-2-million-multi-state-license-agreement/

"Under the terms of a multi-state license agreement, RedTape agreed on the terms to license the patented process and deploy 12 Trichome Separation systems for a total upfront investment of US$10.2 million payable in installments to CryoMass throughout 2023. CryoMass has agreed to deliver the units to RedTape according to a schedule that extends over 24 months. In addition to the installments, RedTape will pay CryoMass 50% of all net revenue generated by the units over the life of the agreement."

First income achieved! $10,2m revenue for the sale of 12 systems and a 50% "royalty" on the revenue generated by these systems.

Bring me to following questions (I'll ask these to management & posts replies here):
1. Sale price per system is $850.000. At what cost can they produce the system? I.e. What will the margins be on a system sale basis?
2. What are the running costs for the deployed systems and who carries them? Installed machinery requires periodic maintenance. When they break down (which will happen at some point), spare parts will be necessary. Is it the customer that carries the cost or CryoMass?
3. What will the revenue be from a single system? Is there an estimation that could let us allow to estimate revenues for Cryomass?
4. What is certainty regarding the revenue? How big is the deviation in yield between a good harvest and a bad harvest?
5. Is there insight in deployment schedule over the next 12 months? Will help to estimate cash flow timing.

The company will need to evolve from a proof of concept towards an enterprise that has a growing production capacity, that can provide maintenance in the field (service agreements opportunity?) and needs to develop further business opportunities (e.g. dealership agreements in other states). When they branch out to other crops, its realistic their R&D division will need to grow as well. Other plants might require specific changes in the process? Many challenges ahead, but a very interesting story!

[byobnet]

I believe we should see a PR regarding installation of the CroyoCann 500CF processing machine at a partner facility in Monterey, CA very soon. Stay tuned!

All posts are my opinions and not investment advice.

[Tiger Money]

I have a feeling we are close to a nice run!

[JDCruz]

Article just hit on CRYM and the CryoCann 500 CF: https://microcapdaily.com/cryomass-technologies-inc-otcmkts-crym-heating-up-as-co-builds-out-patented-cryocann-500-cf-to-process-cannabis-other-high-value-plants/

[mxp]

yes, it is after Jeff made this as his pick.

[Kaizenman]

Looks like Bigger Capital recently took a stake in CRYM:

Made a good size investment in CryoMass. One to watch. $CRYM

— Michael Bigger (@biggercapital) October 12, 2021

Let's Go!

[kairos]

thx ...

[FollowMyNIL]

It was a crypto pick, I do not have a yearly subscription to TCV ((The Crypto Vigilante))


Using Twitter effectively, you should be able to find someone tweeting out the pick by now.



Cheers,

[kairos]

I saw Crypto Vigilante came out with a new pick yesterday, any idea what it was?

[FollowMyNIL]

Another CRYM great day! I been flipping.. flipping last three days been outstanding.. I figured those promotion stocks get bought up early and sell to buy back a few times until the bigger climb.. but dollars I’m holding on for.


I put some profits into,


PLYN TODAY.


((ANOTHER TIP FROM A FRIEND)) no one knows yet!!


INCREDIBLY LOW FLOAT- Trust A Hidden Gem.. Low Volume? Catalyst & Bottom Reversal Starting today. Currently 03’s. Previous $1.60’s 1yr ago.

[Quintessence]

Yes, nice day for CRYM.

[kairos]

On fire ... CRYM

[kairos]

well done and congrats!!

[Quintessence]

I bought back before the symbol and name change, based on the 8-Ks. I figured it was only a matter of time till others noticed CRYM.

[kairos]

As usual some traders took advantage of the buying volume but he is definitely calling for multiple dollars and really likes the technology ...

[Quintessence]

Thanks. This my first experience with this group.

[FollowMyNIL]

Last promotions- 2 went over 30,000% and last one is new, up 600%. Not over.. definitely CRYM High Dollars

[Quintessence]

Is the promo over? Volume and price dropping.

[FollowMyNIL]

CryoMass Will Evolutionize The Cannabis Industry. READ

Welcome to the future of cannabis. You’re in CryoMass territory.

CryoMass Technologies Inc. is developing high- speed processing equipment that can be trucked to any field where commercial hemp or cannabis is being harvested. What the truck delivers is a precision disassembly line for plants. Because the CryoMass system is built to work on site, plants can be fed into it within minutes after cutting – leaving virtually zero time for trichomes to bleed out.

For all the advantages their equipment delivers,
a Cryomass system (based on the company’s patented process for liquid nitrogen separation)
is not expensive for the company to build – under $1 million. But the benefits to a cannabis grower lower costs, more product, higher quality -- are worth more than $1 million ... per week.

CryoMass technology eliminates a long list of labor, capital and other costs, including the costs of:
•Owning a drying house and all the equipment needed to control temperature and humidity
•Owning trucks to bring plants to the drying house
•Loading plants for shipment to the drying house (and then unloading them)
•Handling and monitoring plants at the drying house
•Trimming buds by hand or machine
•Truck fuel
•Electricity to keep the drying house running at the right temperature and humidity

Cryomass technology yields more product, because it captures all the good stuff that nature put in
the trichomes – instead of losing one-third to evaporation.

[FollowMyNIL]

CRYM is futuristic ((THC/CBD liquid nitrogen, what?)) Millions in savings a week..! Technology is solid.

[kairos]

Berwick did some good DD there ... CRYM ... imo

[Renee]

Thanks, LTG. Wow, would have been nice to own this stock today. Nice gain.

Good thoughts your way!!

[lovethatgreen]

Hello Renee!

Canadian Thanksgiving soon

Hope you are well !

[Quintessence]

Thanks. That explains the volume.

[FollowMyNIL]

It’s being advised/promoted as a buy- The Dollar Vigilante

[MomsSpaghetti]

Interesting

[kairos]

[Quintessence]

Nice action today. Up 50% on heavy volume.

[Renee]

Andina Gold Corp., AGOL, changed to Cryomass Technologies Inc., CRYM:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[Quintessence]

Interesting merger news and filings recently.

https://www.prnewswire.com/news-releases/andina-gold-prepares-for-initial-product-launch-301340666.html

https://www.otcmarkets.com/filing/html?id=15113877&guid=5ZekkKk9hQiQfth#EA144867EX2-11_ANDINA_HTM

[C Patrick]

Thanks

[cash4]

Etrade, if you gotta ask, I assume you have Robinhood, the worst platform ever.

[C Patrick]

Which broker do you guys use to trade this security?

[cash4]

American Cannabis Company, Inc. Announces Execution of Non-Binding Letter of Intent for Strategic Acquisition of a 60,000-sq.-ft. Cannabis Cultivation and Extraction Operation in Denver, Colorado

https://www.otcmarkets.com/stock/AGOL/news/American-Cannabis-Company-Inc-Announces-Execution-of-Non-Binding-Letter-of-Intent-for-Strategic-Acquisition-of-a-60000-s?id=286998

Press Release | 01/21/2021

DENVER, CO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that it has successfully executed a non-binding letter of intent (LOI) with Andina Gold Corporation (OTCQB: AGOL) to purchase assets of its Good Meds and BOSM Labs operating division, a fully licensed cultivation and extraction operation in Colorado offering premium cannabis and cannabis extracts to the wholesale and retail medical and recreational markets. Assets are to include one cultivation operation and one hydrocarbon extraction laboratory and production center. All assets to be acquired will operate out of a 60,000-square-foot facility, centrally located in Denver, Colorado. Currently, only 50,000 square feet of space are being utilized, with 10,000 square feet of additional open space ready and available for the Company to use as it looks to scale up operations.

Since 2009, the Good Meds brand has cultivated and provided top-tier cannabis flower products to medical patients and recreational consumers in Colorado. BOSM Labs carries a strong reputation as a high-end manufacturer of well-known hydrocarbon-extracted cannabis products. Combined under one roof, these brands act as one of few long-standing and major contenders in the maturing Denver market.

Christopher Hansen, Chief Executive Officer of Andina Gold Corporation, commented: “We are pleased with the non-binding letter of intent with American Cannabis Company, and look forward to working with Terry Buffalo and his team to complete the transaction. The dedicated, consistently excellent work of Good Meds and BOSM Labs personnel has been the driver of their excellent reputation. We also appreciate the steady leadership through this transitional period provided by Amanda Price and John Haugh. We feel confident the impressive work of Good Meds and BOSM Labs will continue as we hand over the keys to American Cannabis Company.”

Terry Buffalo, Chief Executive Officer and Chief Financial Officer of American Cannabis Company, commented, “This is another strategic move for ACC. Officially having secured two non-binding LOIs to date, ACC will soon integrate three retail dispensaries and a total of 70,000 square feet of combined cultivation and extraction operations. The due diligence process for Good Meds and BOSM Labs has begun, and we anticipate this to close in Q2 of 2021. We analyzed many opportunities both here in Colorado as well as in other states, and we ultimately chose to focus on the Colorado market initially. This approach will allow us to improve existing operational processes, refine our workflow and deploy an operational management platform that we can use as we branch out to other regions of the country.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

For more information about American Cannabis Company, please visit:

www.theacclife.com

www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com

www.americanhempservices.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)

(High Density Cultivation System)

(Cultivation Cube)

(SoHum Living Soils®)

About Good Meds

Founded in 2009, Good Meds medical cannabis dispensaries in Englewood and Lakewood, Colorado offer affordable access to premier cannabis for registered Colorado medical cannabis patients. The company’s carefully curated genetics are grown using the highest quality ingredients, to address a full spectrum of medical ailments. Good Meds generates revenue through its retail sales as well as wholesale products sold to non-Good Meds retail outlets in the recreational market. Good Meds supports the growth of the cannabis industry and abides by responsible business practices. The Good Meds assets were acquired by Andina Gold Corp. in 2019. For more information on Good Meds, please visit: https://www.goodmeds.com/.

About BOSM Labs

Serving the Colorado market since 2017, BOSM Labs balances science and art to produce quality-first, boutique extracts sold at both medical and recreational cannabis outlets. BOSM’s single-source concentrates begin with an artisan cultivation team and end with pronounced flavors that truly capture the essence of the flower at harvest. For more information on BOSM Labs, please visit: https://www.goodmeds.com/bosm-labs/.

Contact:
[e-mail]

303-974-4770

[e-mail]

303-222-8092